NO20071073L - Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer - Google Patents

Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer

Info

Publication number: NO20071073L
Authority: NO; Norway
Prior art keywords: kinase inhibitors; heterocycle; preparation; pharmaceutical use; substituted cyclic
Prior art date: 2004-07-27

Application number

NO20071073A

Other languages

English (en)

Norwegian (no)

Inventor

Jean-Luc Malleron

Hartmut Strobel

Conception Nemecek

Sven Ruf

Kurt Ritter

Dominique Lesuisse

Stefan Guessregen

Anne Lebrun

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-27

Filing date

2007-02-26

Publication date

2007-04-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34931290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20071073(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-02-26 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2007-04-26 Publication of NO20071073L publication Critical patent/NO20071073L/no

Links

ZMGMDXCADSRNCX-UHFFFAOYSA-N 5,6-dihydroxy-1,3-diazepan-2-one Chemical class OC1CNC(=O)NCC1O ZMGMDXCADSRNCX-UHFFFAOYSA-N 0.000 title 1
229940043355 kinase inhibitor Drugs 0.000 title 1
239000003757 phosphotransferase inhibitor Substances 0.000 title 1
229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 abstract 1
239000003909 protein kinase inhibitor Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Obesity (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Immunology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20071073A 2004-07-27 2007-02-26 Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer NO20071073L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04291905A EP1621539A1 (en)	2004-07-27	2004-07-27	Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
PCT/EP2005/008721 WO2006010642A1 (en)	2004-07-27	2005-07-25	Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Publications (1)

Publication Number	Publication Date
NO20071073L true NO20071073L (no)	2007-04-26

Family

ID=34931290

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20071073A NO20071073L (no)	2004-07-27	2007-02-26	Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer

Country Status (20)

Country	Link
US (1)	US20070259891A1 (pt)
EP (2)	EP1621539A1 (pt)
JP (1)	JP2008508229A (pt)
KR (1)	KR20070044440A (pt)
CN (1)	CN1993359A (pt)
AR (1)	AR050267A1 (pt)
AU (1)	AU2005266461A1 (pt)
BR (1)	BRPI0513863A (pt)
CA (1)	CA2571324A1 (pt)
EA (1)	EA200700142A1 (pt)
IL (1)	IL180257A0 (pt)
MA (1)	MA28753B1 (pt)
MX (1)	MX2007000735A (pt)
NO (1)	NO20071073L (pt)
PE (1)	PE20060556A1 (pt)
SG (1)	SG140591A1 (pt)
TW (1)	TW200617004A (pt)
UY (1)	UY29037A1 (pt)
WO (1)	WO2006010642A1 (pt)
ZA (1)	ZA200700706B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7354933B2 (en) *	2003-01-31	2008-04-08	Aventis Pharma Sa	Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP2299266A1 (en)	2003-12-19	2011-03-23	The Regents of the University of California	Methods and materials for assessing prostate cancer therapies
NZ550102A (en)	2004-02-24	2010-10-29	Univ California	Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
EP1621536A1 (en)	2004-07-27	2006-02-01	Aventis Pharma S.A.	Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
US7709517B2 (en)	2005-05-13	2010-05-04	The Regents Of The University Of California	Diarylhydantoin compounds
FR2896504B1 (fr) *	2006-01-23	2012-07-13	Aventis Pharma Sa	Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
FR2896503B1 (fr) *	2006-01-23	2012-07-13	Aventis Pharma Sa	Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
AU2016201061B2 (en) *	2006-03-27	2017-03-02	The Regents Of The University Of California	Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2012241184B2 (en) *	2006-03-27	2016-01-07	The Regents Of The University Of California	Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
AU2013205325B2 (en) *	2006-03-27	2016-03-24	The Regents Of The University Of California	Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
BRPI0709771B1 (pt) *	2006-03-27	2022-01-25	The Regents Of The University Of California	Composto e composição farmacêutica
NZ596260A (en) *	2006-03-29	2013-05-31	Univ California	Diarylthiohydantoin compounds
PE20110371A1 (es)	2006-08-15	2011-06-24	Novartis Ag	COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA
US8835426B2 (en) *	2007-02-26	2014-09-16	Vitae Pharmaceuticals, Inc.	Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5451611B2 (ja) *	2007-07-26	2014-03-26	ヴァイティーファーマシューティカルズ，インコーポレイテッド	１１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックインヒビター
TWI469971B (zh)	2007-10-26	2015-01-21	Univ California	二芳基乙內醯脲類化合物
AR069207A1 (es) *	2007-11-07	2010-01-06	Vitae Pharmaceuticals Inc	Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
CA2708303A1 (en)	2007-12-11	2009-06-18	Vitae Pharmaceuticals, Inc.	Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) *	2008-01-07	2009-08-16	Vitae Pharmaceuticals Inc	Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en)	2008-01-24	2009-07-30	Vitae Pharmaceuticals, Inc.	Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) *	2008-02-11	2009-08-20	Vitae Pharmaceuticals, Inc.	1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
US8598160B2 (en) *	2008-02-15	2013-12-03	Vitae Pharmaceuticals, Inc.	Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CA2715947C (en)	2008-02-20	2016-10-25	Novartis Ag	Heterocyclic inhibitors of stearoyl-coa desaturase
CA2718264A1 (en) *	2008-03-18	2009-09-24	Vitae Pharmaceuticals, Inc.	Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
EP2291370B1 (en)	2008-05-01	2013-11-27	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW201004945A (en)	2008-05-01	2010-02-01	Vitae Pharmaceuticals Inc	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723032A1 (en) *	2008-05-01	2009-11-05	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20110002492A (ko)	2008-05-01	2011-01-07	비타이 파마슈티컬즈, 인코포레이티드	11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
WO2010011314A1 (en)	2008-07-25	2010-01-28	Boehringer Ingelheim International Gmbh	Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8846668B2 (en)	2008-07-25	2014-09-30	Vitae Pharmaceuticals, Inc.	Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5679997B2 (ja)	2009-02-04	2015-03-04	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
TW201039034A (en) *	2009-04-27	2010-11-01	Chunghwa Picture Tubes Ltd	Pixel structure and the method of forming the same
UA109255C2 (ru)	2009-04-30	2015-08-10	Берінгер Інгельхайм Інтернешнл Гмбх	Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
KR20120061771A (ko) *	2009-04-30	2012-06-13	비타이 파마슈티컬즈, 인코포레이티드	11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
HRP20131122T1 (hr)	2009-05-12	2013-12-20	Janssen Pharmaceuticals, Inc.	Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
WO2011011123A1 (en)	2009-06-11	2011-01-27	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en)	2009-07-01	2011-01-06	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CN102639700A (zh)	2009-09-30	2012-08-15	哈佛大学校长及研究员协会	通过调节自噬增强基因产物调节自噬的方法
EP3124481B1 (en)	2010-02-16	2018-03-28	Aragon Pharmaceuticals, Inc.	Androgen receptor modulators and uses thereof
EP2582698B1 (en)	2010-06-16	2016-09-14	Vitae Pharmaceuticals, Inc.	Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en)	2010-06-25	2011-12-29	Boehringer Ingelheim International Gmbh	Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CA2813671A1 (en)	2010-11-02	2012-05-10	Boehringer Ingelheim International Gmbh	Pharmaceutical combinations for the treatment of metabolic disorders
WO2014052237A1 (en)	2012-09-26	2014-04-03	Aragon Pharmaceuticals, Inc.	Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
EP2945628B1 (en)	2013-01-15	2020-04-15	Aragon Pharmaceuticals, Inc.	Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer
CA2974512C (en)	2015-03-31	2019-07-09	Halliburton Energy Services, Inc.	Polymeric viscosifiers for use in water-based drilling fluids
TWI726969B (zh)	2016-01-11	2021-05-11	比利時商健生藥品公司	用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR20240096623A (ko)	2017-10-16	2024-06-26	아라곤 파마슈티컬스, 인코포레이티드	비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
AU2019387367A1 (en)	2018-11-30	2021-06-10	Nuvation Bio Inc.	Diarylhydantoin compounds and methods of use thereof
US20220235068A1 (en) *	2019-05-30	2022-07-28	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Tetracyclic compounds as cdc7 inhibitors
UY40826A (es) *	2023-07-18	2025-01-31	Horizon Therapeutics Ireland Dac	Inhibidores ra2s heterocíclicos de igf-1r para el tratamiento de enfermedades
CN122249431A (zh) *	2023-11-17	2026-06-19	中国药科大学	作为雄激素受体(ar)拮抗剂的化合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411981A (en) *	1991-01-09	1995-05-02	Roussel Uclaf	Phenylimidazolidines having antiandrogenic activity
AU2390892A (en) *	1991-08-08	1993-03-02	Yamanouchi Pharmaceutical Co., Ltd.	Urea derivative
DE19540027A1 (de) *	1995-10-27	1997-04-30	Gruenenthal Gmbh	Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
DE19732928C2 (de) *	1997-07-31	2000-05-18	Gruenenthal Gmbh	Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
FR2796945B1 (fr) *	1999-07-30	2002-06-28	Sod Conseils Rech Applic	Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
US6114365A (en) *	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US20030134836A1 (en) *	2001-01-12	2003-07-17	Amgen Inc.	Substituted arylamine derivatives and methods of use
FR2837201A1 (fr) *	2002-03-18	2003-09-19	Servier Lab	Nouveaux composes derives de la quinazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2002951247A0 (en) *	2002-09-06	2002-09-19	Alchemia Limited	Compounds that interact with kinases
US7354933B2 (en) *	2003-01-31	2008-04-08	Aventis Pharma Sa	Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621536A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

2004
- 2004-07-27 EP EP04291905A patent/EP1621539A1/en not_active Withdrawn
2005
- 2005-07-25 MX MX2007000735A patent/MX2007000735A/es not_active Application Discontinuation
- 2005-07-25 BR BRPI0513863-9A patent/BRPI0513863A/pt not_active IP Right Cessation
- 2005-07-25 EA EA200700142A patent/EA200700142A1/ru unknown
- 2005-07-25 WO PCT/EP2005/008721 patent/WO2006010642A1/en not_active Ceased
- 2005-07-25 CN CNA2005800255207A patent/CN1993359A/zh active Pending
- 2005-07-25 PE PE2005000867A patent/PE20060556A1/es not_active Application Discontinuation
- 2005-07-25 KR KR1020077002138A patent/KR20070044440A/ko not_active Withdrawn
- 2005-07-25 SG SG200801117-3A patent/SG140591A1/en unknown
- 2005-07-25 EP EP05776537A patent/EP1773828A1/en not_active Ceased
- 2005-07-25 AU AU2005266461A patent/AU2005266461A1/en not_active Abandoned
- 2005-07-25 JP JP2007523039A patent/JP2008508229A/ja active Pending
- 2005-07-25 ZA ZA200700706A patent/ZA200700706B/xx unknown
- 2005-07-25 AR ARP050103073A patent/AR050267A1/es unknown
- 2005-07-25 CA CA002571324A patent/CA2571324A1/en not_active Abandoned
- 2005-07-26 TW TW094125193A patent/TW200617004A/zh unknown
- 2005-07-27 UY UY29037A patent/UY29037A1/es unknown
2006
- 2006-12-21 IL IL180257A patent/IL180257A0/en unknown
2007
- 2007-01-26 US US11/627,505 patent/US20070259891A1/en not_active Abandoned
- 2007-01-29 MA MA29637A patent/MA28753B1/fr unknown
- 2007-02-26 NO NO20071073A patent/NO20071073L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MX2007000735A (es)	2007-03-30
EP1621539A1 (en)	2006-02-01
BRPI0513863A (pt)	2008-05-20
UY29037A1 (es)	2006-02-24
CN1993359A (zh)	2007-07-04
KR20070044440A (ko)	2007-04-27
CA2571324A1 (en)	2006-02-02
PE20060556A1 (es)	2006-07-03
EA200700142A1 (ru)	2007-08-31
US20070259891A1 (en)	2007-11-08
MA28753B1 (fr)	2007-07-02
EP1773828A1 (en)	2007-04-18
WO2006010642A1 (en)	2006-02-02
AU2005266461A1 (en)	2006-02-02
IL180257A0 (en)	2007-07-04
SG140591A1 (en)	2008-03-28
AR050267A1 (es)	2006-10-11
ZA200700706B (en)	2008-10-29
JP2008508229A (ja)	2008-03-21
TW200617004A (en)	2006-06-01

Legal Events

Date	Code	Title	Description
2010-03-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
EA200700142A1 (ru)	2007-08-31	Замещенные гетероциклом циклические производные мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназы
NO20071074L (no)	2007-04-27	Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
NO20071504L (no)	2007-05-25	Pyrimidinderivanter.
NO20090628L (no)	2009-04-21	Pyridizinon derivativater
NO20066055L (no)	2007-01-24	Pyridinderivater
NO20071593L (no)	2007-05-22	Pyrimidinderivater
NO20090202L (no)	2009-03-23	Prolylhydroksylaseinhibitorer
NO20073791L (no)	2007-08-30	Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20074634L (no)	2007-10-31	Substituerte heterocykler og deres anvendelse som CHK1-, PDK1- og PAK-inhibitorer
NO20081893L (no)	2008-05-20	4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft
NO20090295L (no)	2009-01-20	Substituerte heteroarylderivater
NO20063468L (no)	2006-11-15	Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
NO20083214L (no)	2008-09-01	Pyrimidinylarylurea-derivater som omdannes til FGF-inhibitorer
NO20082976L (no)	2008-09-10	Svovelholdige cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
NO20091553L (no)	2009-04-20	Fenylderivater og deres anvendelse som immunmodulatorer
NO20050828L (no)	2005-04-05	lndol-3-svovelderivater
ATE365551T1 (de)	2007-07-15	Fusionierte heteroaryl-derivative zur verwendung als p38 kinase inhibitoren zur behandlung von u.a rheumatischer arthritis
NO20063925L (no)	2006-09-01	Indazolderivater som inhibitorer av hormonsensitiv lipase
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20063599L (no)	2006-10-27	Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
UA99617C2 (ru)	2012-09-10	Производные пирролконденсированного азотсодержащего гетероцикла, их получение и фармацевтическое применение
NO20081001L (no)	2008-03-25	Derivater av karboksamid som antagonister for muskarinisk reseptor
NO20054329L (no)	2005-11-21	Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike
NO20092286L (no)	2009-08-13	Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20085107L (no)	2008-12-08	Spirosykliske nitriler som proteaseinhibitorer